After intravenous (IV) injection with factor-dependent FDC-P1 cells, irradiated DBAIP and BALB/c mice developed transplantable leukemias owing to neoplastic transformation of the injected cells in vivo. Increasing the radiation dose shortened the preleukemic latent period, and in female mice the frequency of leukemia development was higher and the latent period shorter than in male mice. In the preleukemic period, the injected FDC-PI cells rapidly increased in number in hematopoietic organs of irradiated animals, reaching peak levels 3 to 5 weeks after injection; factor-independent transformed cells were not detected EUKEMOGENIC EFFECTS of ionizing radiation ap-L pear to be based both on direct damage to the DNA of exposed cells' and indirect host effects that may include activation of endogenous viruses, immunologic impairment, and perturbations in the homeostatic mechanisms.2
0006-4971/90/7501-0030%3.00/0 before day 45. In unirradiated animals, these events were delayed by several weeks, and long-term survivors did not harbor detectable FDC-P1 cells. FDC-P1 cells sampled from preleukemic mice frequently showed atypical colony formation and reduced cloning efficiency in vitro, suggesting the occurrence of a distinct preleukemic change. U16.6 cells produced leukemia only in irradiated recipients, and the leukemic cells usually remained factor dependent. The two contrasting models should be of value in further analyzing the mechanisms underlying radiation-induced leukemias. 0 1990 by The American Society of Hematology.
animals of 1.5 m. Intravenous (IV) injections (lo6 cells) were administered in the tail veins within 2 hours of irradiation.
Factor-dependent cell lines. The factor-dependent hematopoietic cell lines FDC-PI-' (originally provided by Dr T.M. Dexter, Paterson Laboratories, Manchester, England), 32D cl 3'. ' and B6SutA cl 17' (provided by Dr J.S. Greenberger, University of Massachusetts, Worcester) were originally derived from long-term bone marrow (BM) cultures of DBA/2, C3H/HeJ, and C57Bl mice, respectively. The lines T59, U16.6, and U22.3 were generated by infection of CBA fetal liver cells with a retrovirus carrying the c-myb gene' (supplied by Dr T. Gonda, Ludwig Institute for Cancer Research, Melbourne, Australia). The frequency of spontaneous transformation in vitro to autonomous cells in the FDC-P1 cell line in use in this laboratory has recently been estimated" to be less than All cell lines were maintained in suspension cultures in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS), and passaged once or twice weekly. Various experiments with DBA/2 and BALB/c mice were started during a 6-month period. The granulocyte-macrophage colony-stimulating factor (GM-CSF)-responsive lines FDC-P1, T59, U16.6, and U22.3 were stimulated with 10% semipurified mouse lung conditioned medium (MLCM), and the multipotential CSF (Multi-CSF)-responsive lines 32D and B6SutA were stimulated with 10% conditioned medium from WEHI-3B D-cells. 4 Moribund animals or animals used in time-course studies were anesthetized, bled from the eye for white blood cell (WBC) counts and hematocrits, and killed by axillary bleeding. Blood was collected in heparinized syringes, centrifuged at 400 x g for 10 minutes for collection of the plasma, and the cell pellet was resuspended in 2 mL Eisen's solution and density-fractionated with Ficoll-Hypaque (density:l.O77 g/mL; Pharmacia, Uppsala, Sweden).
Spleen, thymus, and pooled mesenteric, inguinal, and axillary lymph nodes were collected, weighed, and passed through stainlesssteel sieves with glass plungers to prepare cell suspensions. To minimize loss of viability, lymph node cells were washed in culture medium immediately after sieving. Pooled BM cells were obtained by flushing the BM from both femurs.
Cell viabilities, determined by eosin exclusion, were 80% to 100% for BM, spleen, thymus, and mononuclear blood cells and approximately 50% for lymph node cells. The data refer to viable cells only.
Colony and cluster formation by normal progenitor cells and cells from continuous cell lines was analyzed using 1-or 5-mL agar c u l t~r e s .~
In experiments involving GM-CSF-responsive cell lines, the cultures were stimulated with 400 U native GM-CSF semipurified from MLCM." For Multi-CSF-responsive lines, mouse spleen cell-conditioned medium was used as a stimulus."
To determine the frequency of untransformed FDC-PI cells, an aliquot of the cell suspension comprising 10% to 20% of the total Tissue sampling for culture and histology.
Colony assays.
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Blood, Vol 75, No 1 (January 1). 1990: pp [190] [191] [192] [193] [194] [195] [196] [197] sample (ie, lo6 to 2 x lo7 cells depending on the organ studied) was cultured in MLCM-stimulated dishes at densities ranging from lo' to 106/mL. Individual FDC-PI cells were identified by their capacity to form large compact colonies, which, in contrast to normal hematopoietic progenitor cells, increased in size when the culture period was extended to 14 days. For detection of factor-independent leukemic FDC-P1 cell variants, the remainder of the cell sample was cultured in unstimulated cultures (for thymus and spleen, the analysis was limited to a maximum of 4 x lo7 cells per mouse). Mixing experiments showed that added normal cells did not interfere with detection of FDC-P1 cells or stimulate colony formation by these cells. Similarly, growth of factor-independent FDC-P1 variants4 was not inhibited by added normal cells. Data refer to calculated total FDC-P1 numbers per organ, per whole blood (assumed to be 1.5 mL), or per two femurs. Generation of cell lines and collection of conditioned media. Cloned cell lines were generated from individual colonies in agar cultures and analyzed as described previously! Conditioned media from factor-independent lines were collected from overgrown cultures after a culture period of at least 2 weeks4 Metaphase preparations were prepared according to a protocol described previ~usly.~ Bioassays were performed in microwell cultures by adding serial twofold dilutions of 5 pL conditioned media or filtered, 1:4 prediluted plasmas to 10 pL medium containing 200 FDC-P1 cells (responding to GM-CSF and Multi-CSF) or 32D cells (responding only to multi-CSF).","
Bioassays for GM-CSF and multi-CSF. Figure 1 shows that with doses different radiation doses. greater than 100 rad, there was a significant shortening of the latent period to leukemia development. As in previous studies,' irradiation between 250 and 600 rad was invariably followed by leukemia development, but in unirradiated recipients the incidence of leukemia varied from experiment to experiment. Experiments A and B in Fig 1 show that one factor contributing to this variability was the sex of the mice injected. The percentage of females irradiated with 0 to 50 rad developing FDC-Pl 4erived leukemias (100%) was higher than that of similarly pretreated males (47%) ( P < ,Ol), and the mean latent period was shorter in female mice (161 days) than in male mice (191 days) (P < .01). No obvious sex differences were found among animals irradiated with 250 to 600 rad.
RESULTS
FDC-PI-derived leukemias in DBAI2 mice: Effects of
Behavior of injected FDC-PI cells in DBA/2 mice in the preleukemic phase. Normal hematopoietic progenitor cells disappear almost completely from the circulation within 1 hour after IV injection.'' One hour after injection of lo6 FDC-P1 cells, the total numbers of FDC-P1 cells recovered were 2,000 to 20,000 in blood, 100 to 600 in pooled femoral BM, 3,000 to 7,000 in spleen, 0 to 20 in thymus, and 0 to 5 in pooled lymph nodes (n = 4). The numbers were almost identical for unirradiated and irradiated (600 rad) animals and did not change significantly during the next 24 hours except for a complete disappearance of the cells from the circulation. Calculation from these data indicated that initially no more than 2% of the injected cells seeded in the BM and lymphoid organs.
After the initial period of seeding, FDC-PI cells were temporarily undetectable in unirradiated recipients. However, a sharp increase in the number of FDC-P1 cells was observed in recipients irradiated with 600 rad, reaching peak levels of approximately 5 x lo5 cells in femoral marrow and lo7 cells in the spleen by about 3 weeks after injection ( Fig  2) . A more delayed increase was observed in lymph nodes and thymus, in which peak numbers of untransformed FDC-P1 cells of approximately lo4 or lo5 cells, respectively, were attained 5 weeks after injection. Table 1 shows that in BM the rapid expansion of the FDC-P1 cell population coincided with regeneration of normal hematopoietic cells after radiation-induced depletion. Comparable changes in FDC-P1 and normal cells were observed in the spleens of irradiated mice. Recovery from radiation damage was essentially complete after 3 weeks, and in the subsequent period total numbers of FDC-PI cells remained relatively constant in all organs, without progressive increase until the emergence of leukemic cells (Fig 2, Table 1 ).
In unirradiated mice, the injected FDC-P1 cells showed a much slower increase in number. Characteristically, they first reappeared in spleen and BM and much later in lymph nodes and thymus. In female mice, these changes were noted a t least 4 weeks earlier than in male mice (Fig 2) .
The rate of accumulation of FDC-PI cells in recipient mice was inversely correlated with the dose of radiation, although initially equal numbers of FDC-P1 cells homed in the BM at each dose level tested (Fig 3) .
Histologic examination of the brain, eye, salivary gland, lung, heart, diaphragm, liver, kidney, gut, testis, thigh muscle, and tibia failed to show obvious foci of FDC-P1 cells in these organs at any stage before onset of leukemia (60 days for irradiated mice, 133 days for unirradiated mice).
One possible explanation for the differing behavior of FDC-P1 cells in irradiated versus unirradiated hosts was that an increased production of GM-CSF or Multi-CSF may have been induced by irradiation and may have stimulated proliferation of the injected FDC-P1 cells. Plasma samples from the irradiated recipients invariably lacked stimulating §Increase in CFC numbers with increasing age was also observed in untreated DBAI2 mice (data not shown).
because leukemia was frequently associated with abnormally low BM cells and CFC numbers and extremely high FDC-P 1 cell numbers. activity for FDC-PI and 32D cells, however, indicating an absence of detectable GM-CSF and Multi-CSF.
In mice irradiated with 600 rad, factor-independent (presumptively leukemic) FDC-P1 variants were first observed 45 days after injection. After this time, the percentage of mice harboring leukemic clones increased continuously (Fig 2) , but the pattern of organs involved varied from animal to animal.
In unirradiated mice, a pronounced sex difference was observed in the temporal appearance of leukemic clones ( Table 1) . The first female mouse developed leukemia 70 days after injection, and all had developed leukemia by day 133 in this particular group of animals. In contrast, in unirradiated male animals leukemic clones were not detected before day 131, and most mice analyzed after this time contained no transformed cells. FDC-P1 cells were undetectable in 6 of 7 unirradiated male recipients killed 7 to 20 months after injection (Table 1) .
Qualitative changes in FDC-PI cells from preleukemic recipients. During the first month after injection, most FDC-P1 cells recovered from the various organs were indistinguishable from the original FDC-PI cells. Individual colonies grown from such cells invariably gave rise to continuous cell lines exhibiting the karyotypic characteristics of FDC-P1 cells (eight metacentric chromosome^).'^ Of 24 FDC-P1 subclones isolated from the BM of 4 irradiated mice 9 to 1 1 days after injection, 22 showed recloning properties in agar culture identical to those of the original FDC-P1 cells injected. However, two clones differed in generating colonies
Transformation of FDC-PI cells.
of substantially smaller size or colonies composed of dispersed cells rather than the usual compact FDC-P1 colonies.
At later timepoints, the tissues of nonleukemic mice contained an increasing proportion of FDC-PI cells forming morphologically abnormal colonies. The percentage of altered FDC-P1 cells was much higher in BM, spleen, and blood cell cultures than in cultures from lymph node and thymus cells. Changes included formation of colonies of reduced size or exhibition of a halo of dispersed cells around a tight colony center. In other instances, the developing clones were reduced to the size of clusters. Individual colonies and clusters from such cultures were expanded in MLCM-stimulated liquid culture and karyotyped. A detailed analysis was made of 58 colonies and clusters in cultures from one animal irradiated with 600 rad and killed 59 days after injection and two unirradiated mice apparently nonleukemic and killed 148 days after injection. Compact colonies with typical FDC-PI morphology gave rise to continuous lines in 67% to 100% of attempts, but continuous growth was observed only with 17% to 50% of the colonies with halo formation and 0% to 33% of clusters of suspected FDC-P1 origin. All continuous lines showed the karyotype of FDC-P1 cells. Fifteen of the FDC-P1 subclones derived from individual abnormal colonies were maintained in suspension culture for 1 to 2 months and then were recultured in agar. Virtually all these lines formed abnormal colonies or clusters identical in morphology to those from which they had originally been generated. These subclones generally showed a remarkably low cloning efficiency of only 0.2% to 30% as compared with that of FDC-P1 cells (60% to 95%) but, unlike leukemic cells, retained their C S F dependency. Common H2-alleles in DBA/2 and BALB/c mice allow transplantation of the DBA/2-derived FDC-P1 cells to BALB/c mice with little risk of immediate reje~tion.'~ In BALB/c mice injected with FDC-P1 cells, the frequency of leukemia, effects of different radiation doses, expansion of the cell population in the preleukemic phase, and morphologic findings in leukemic mice were comparable with the observations made of DBA/2 (Table 2, Fig 4) . The differences between males and females were even more pronounced than in DBA/2 mice and were evident even in recipients that received 600 rad irradiation (Fig 4) . The mean latent period to leukemia development in female BALB/c mice irradiated with 600 rad (6 weeks, Fig 4) was shorter than in similarly pretreated DBA/2 mice (1 1.5 weeks, Fig 1) .
Cell populations from six leukemic BALB/c mice cultured in agar contained varying proportions of factor-independent FDC-P1 variants. As for leukemias in DBA/2 mice,' the success rate of establishing cell lines from leukemic colonies varied between 0% and 100%. Thirty-two factor-independent lines were established from five leukemic mice. As in the FDC-PI /DBA/2 system: most of these autonomous leukemic lines secreted no detectable amount of GM-CSF or Multi-CSF.
Intravenous injection of lo6 U16.6 cells into CBA mice irradiated with 350 rad was invariably followed by development of a fatal leukemialike disease after an interval of 6 to 9 months. Unirradiated recipients, however, failed to show signs of FDC-P1-derived leukemias in BALBIc mice.
U16.6derived leukemias in CBA mice. disease, and tissues from two such mice studied 11 to 13 months after injection showed no morphologic changes and contained no abnormal clonogenic cells. Irradiated mice with U16.6-derived leukemias had moderate spleen (1 50 to 300 mg) and lymph node enlargement, but the lymph nodes had the typical greenish color of chloromas. Cytocentrifuge preparations of BM showed 89% to 94% promyelocytelike cells (Fig 5a) and the spleen contained 30% to 45% of similar cells. Portal liver infiltrations and perivascular kidney infiltrations were observed, and foci of hematopoi- etic cells in the perirenal tissue or the myocardium (Fig 5b) . The peripheral blood showed decreased hematocrits (40%) and low WBC counts (1,700 to 2,60O/mL) with occasional promyelocytelike cells. Karyotypes prepared from BM and lymph nodes showed that most metaphases had three metacentric chromosomes, the cytogenetic hallmark of the injected U16.6 cells (Fig 5c and d) .
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CSF-stimulated agar cultures of BM, spleen, and lymph node cells from leukemic mice developed numerous small to medium colonies, but no colonies developed in unstimulated cultures. This growth pattern was similar to that of the original U16.6 cells,' although typically the leukemic U16.6 cells formed smaller colonies. Eleven of 12 colonies grown from leukemic BM generated continuous GM-CSF-dependent cell lines after transfer to liquid culture, and these displayed cloning properties in agar cultures similar to those of the original U16.6 cells. Transplantation of leukemic cells to unirradiated recipients failed to produce transplanted leukemia except in one recipient, in which a readily transplantable autonomous leukemia developed.
IV injection of lo6 T59, U22.3, 32D cl 3, and B6SutA cl 17 cells failed to induce leukemias in groups of 8 to 24 unirradiated mice or syngeneic recipient mice irradiated with 350 rad. Histologic sections, cytocentrifuge preparations, chromosome studies, and tissue cultures indicated no abnormalities at 9 to 20 months after injection.
Malignancies in noninjected irradiated control mice. Sixteen male and 17 female DBA/2 mice and 16 female CBA mice were irradiated with 350 rad and followed for 15 months. Neoplastic diseases in DBA/2 mice included thymic lymphomas in four female mice (9 to 14 months after irradiation) and a soft tissue tumor in one female (14 months). In one CBA mouse, an ovarian tumor developed after 13 months.
Other cell lines.
DISCUSSION
Two of six factor-dependent cell lines tested in these studies were capable of continued proliferation in hematopoietic tissues of irradiated IV-injected syngeneic recipients, with eventual development of leukemia. In the FDC-P1/ DBA/2 system, the latent period to leukemia development was influenced by the previous irradiation dose of the recipients. In this context, it is probably significant that the emergence of factor-independent leukemic clones was preceded by a significant proliferation of untransformed FDC-PI cells dose dependently accelerated by irradiation of the recipient animals. Primary seeding by injected FDC-PI cells of host organs was not affected by irradiation, but irradiation enhanced the ability of FDC-PI cells to proliferate and/or accumulate in a manner that was not uniform in the various tissues. Stromal BM cells have been shown to support the growth of FDC-PI cells in an ability that can be significantly enhanced by irradiati~n.'~.'".'~ In part, this stimulating activity is attributable to GM-CSF,".I9 although additional regulators could be involved.'"2' The amounts of GM-CSF secreted by irradiated stromal cells are generally very I O W , '~. '~ and much of the C S F may be held locally in the glycohalix of stromal cells."." Therefore, the undetectability of GM-CSF and Multi-CSF in the plasmas of irradiated mice does not rule out an increased local production of these factors as an influence on the behavior of FDC-PI cells in irradiated recipients.
Like normal hematopoietic progenitor cells, FDC-PI cells also respond to negative regulatory ~i g n a l ,~' and the number of untransformed FDC-PI cells reached a plateau in recipient mice, the beginning of which coincided with recovery of the tissues from radiation injury. This suggests that the engrafted FDC-PI cell population was responsive to the same regulatory signals that orchestrated regeneration of the normal hematopoietic population after radiation.
In unirradiated mice, injected FDC-PI cells seeded efficiently but then became temporarily undetectable. FDC-PI cells eventually reappeared and reached plateau levels similar to those in irradiated mice, although with a significant delay. Although leukemic transformation of the FDC-PI cells occurred in some of the unirradiated animals between 3 and 6 months after injection, it was of interest that most unirradiated recipients studied beyond that time did not harbor detectable FDC-PI cells, even of untransformed type. This suggests that many unirradiated mice are able eventually to suppress or eliminate the injected cells.
In the FDC-PI /BALB/c system, the buildup in FDC-PI cells was more rapid, the latent interval to leukemia development was shorter, and the final incidence of leukemia was higher in female than in male mice. A similar phenomenon was observed in BALB/c recipients. Sex differences in leukemia development in mice have been noted previously and may relate to the effects of sex hormones or to intrinsic differences between male and female hematopoietic t i s s~e s .~~.~'
With increasing time after injection, the in vitro cloning properties of tissue-derived FDC-P1 cells became more and more atypical. These altered properties appeared to be stable genetic alterations in the cells. These altered growth characteristics potentially represent the evolution in the animals of genuine preleukemic clones, possibly by selection of rare variants in the original population injected or by secondary changes occurring in the engrafted cells.
The simplest interpretation of the effects of host irradiation on leukemic transformation of injected FDC-PI cells is that irradiated tissues support the more rapid accumulation of FDC-PI cells that subsequently have a fixed probability of undergoing secondary changes leading to leukemic transformation. This cannot represent the entire contribution of the irradiated host, however, because leukemic transformation is rare in much larger populations of these cells maintained in vitro.3
Irradiation appeared to be an absolute prerequisite for development of leukemia in recipients of U16.6 cells but, unlike the FDC-PI system, there was no unambiguous evidence for transformation of the cells in the irradiated recipients. The production of leukemia by U16.6 cells may simply be owing to enhanced host stimulation of the injected cells resulting from the irradiation. The effects of radiation on stromal BM cells are more lasting than those on hematopoietic ~e l l s ,~~,~~ and increased production of CSFs has been observed for at least 4 months." The U16.6 system therefore may be a more simple model in which to study effects of irradiation on the ability of host tissues to promote the growth of potential tumor
